| Literature DB >> 30566882 |
Toru Uchimura1, Yoshitaka Oyama1, Meng Deng2, Haitao Guo1, Justin E Wilson1, Elena Rampanelli1, Kevin D Cook3, Ichiro Misumi3, Xianming Tan4, Liang Chen1, Brandon Johnson1, Jason Tam1, Wei-Chun Chou1, W June Brickey1, Alex Petrucelli1, Jason K Whitmire5, Jenny P Y Ting6.
Abstract
Appropriate immune responses require a fine balance between immune activation and attenuation. NLRC3, a non-inflammasome-forming member of the NLR innate immune receptor family, attenuates inflammation in myeloid cells and proliferation in epithelial cells. T lymphocytes express the highest amounts of Nlrc3 transcript where its physiologic relevance is unknown. We show that NLRC3 attenuated interferon-γ and TNF expression by CD4+ T cells and reduced T helper 1 (Th1) and Th17 cell proliferation. Nlrc3-/- mice exhibited increased and prolonged CD4+ T cell responses to lymphocytic choriomeningitis virus infection and worsened experimental autoimmune encephalomyelitis (EAE). These functions of NLRC3 were executed in a T-cell-intrinsic fashion: NLRC3 reduced K63-linked ubiquitination of TNF-receptor-associated factor 6 (TRAF6) to limit NF-κB activation, lowered phosphorylation of eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1), and diminished glycolysis and oxidative phosphorylation. This study reveals an unappreciated role for NLRC3 in attenuating CD4+ T cell signaling and metabolism.Entities:
Keywords: CD4(+) T cell response; EAE; LCMV infection; NLRC3; NOD-like receptors; T cell receptor signaling; autoimmunity; inflammatory pathways
Mesh:
Substances:
Year: 2018 PMID: 30566882 PMCID: PMC6532657 DOI: 10.1016/j.immuni.2018.10.008
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745